Skip to main content

Day: September 28, 2023

TDC NET A/S – Publication of Base Prospectus

  NOT INTENDED FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN THE UNITED STATES. NOT INTENDED FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, TO ANY PERSON IN ANY JURISDICTION WHERE RELEASE, PUBLICATION OR DISTRIBUTION TO SUCH PERSON IS RESTRICTED BY ANY LAW OR REGULATION APPLICABLE IN SUCH JURISDICTION. THIS ANNOUNCEMENT IS NOT AN OFFER TO SELL OR ISSUE OR INVITATION TO PURCHASE OR SUBSCRIBE FOR, OR ANY SOLICITATION OF AN OFFER TO PURCHASE OR SUBSCRIBE FOR, ANY SECURITIES. Copenhagen, 28 September 2023: TDC NET A/S (“TDC NET”) today announces that the Base Prospectus dated 28 September 2023 (the “Base Prospectus”) in relation to TDC NET’s EUR 3,500,000,000 Euro Medium Term Note (EMTN) programme has been approved by the Luxembourg Commission de Surveillance du Secteur Financier. The Base Prospectus...

Continue reading

Xos Customers in Canada Can Save $100,000 CAD with iMHZEV Incentive

Xos stepvan driving in mountanious wooded area.Xos stepvan driving in mountanious wooded area.LOS ANGELES, Sept. 28, 2023 (GLOBE NEWSWIRE) — Xos, Inc. (NASDAQ: XOS) is pleased to announce that its stepvans are now eligible for the Incentives for Medium- and Heavy-Duty Zero-Emission Vehicles Program (iMHZEV) from the Government of Canada. This significant development marks a milestone in the company’s commitment to advancing the adoption of electric vehicles in Canada.The iMHZEV Program, administered by Transport Canada, aims to incentivize the adoption of medium- and heavy-duty zero-emission vehicles (ZEVs) by Canadian businesses. Eligible Canadian purchasing and leasing organizations can benefit from iMHZEV Program incentives, promoting sustainability and environmental responsibility in the commercial vehicle...

Continue reading

Solar Integrated Roofing Corp. Provides Corporate and Operational Update

HENDERSON, Nev., Sept. 28, 2023 (GLOBE NEWSWIRE) — Solar Integrated Roofing Corp. (OTC: SIRC) (“SIRC” or the Company”), an integrated, single-source solutions provider of solar power, roofing and EV charging systems, provided a corporate and operational update. “Our plan to consolidate operations while growing revenue and improving margins remains on course,” said Brad Rinehart, Chief Executive Officer of SIRC. “We just launched our new, consolidated facility in San Diego for our McKay and Milholland subsidiaries and we are finalizing the tenant improvements for the property this week. “We continue to have a dialog with Tribeca Energy on the Letter of Commitment we have with them. We are working towards consummating that arrangement when both Tribeca Energy and SIRC are prepared to do so and at a valuation that will enable shareholders...

Continue reading

Fairfax India Announces Intention to Make a Normal Course Issuer Bid

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES TORONTO, Sept. 28, 2023 (GLOBE NEWSWIRE) — Fairfax India Holdings Corporation (“Fairfax India”) (TSX: FIH.U) announces that the Toronto Stock Exchange (the “TSX”) has accepted a notice filed by Fairfax India of its intention to commence a Normal Course Issuer Bid for its Subordinate Voting Shares through the facilities of the TSX (or other alternative Canadian trading systems) effective September 30, 2023. Purchases will be made in accordance with the rules and policies of the TSX and the Subordinate Voting Shares purchased by Fairfax India will be cancelled. The notice provides that Fairfax India’s board of directors has approved the purchase on the TSX, during the period commencing September 30, 2023 and ending September 29, 2024, of up to...

Continue reading

QIAGEN’s QuantiFERON solutions recommended for use by kidney specialists in Tunisia

Tunisian Society of Nephrology first professional body in the field to publish nationwide guidance Association of specialists recommends national immune response monitoring for cytomegalovirus (CMV) after kidney transplant Professional vote of confidence in QuantiFERON-CMV, QuantiFERON Monitor and QuantiFERON-TB Gold PlusTUNIS, Tunisia, Sept. 28, 2023 (GLOBE NEWSWIRE) — QIAGEN today announced that the comprehensive QuantiFERON immune response blood tests have been recommended for use by clinicians in Tunisia to help kidney disease, transplant and dialysis patients – the world’s first-ever guidance of this type by a professional body in kidney medicine. To catch potentially deadly complications as early as possible, the Tunisian Society of Nephrology (TSN) advises specialist clinicians to use QuantiFERON-CMV to gauge the immune...

Continue reading

Stack Capital Holding Hopper Announces Strategic Partnerships With Hotelbeds & WebBeds

Hopper customers and its B2B partners gain access to 700,000+ hotel properties worldwideSTACK CAPITAL HOLDING HOPPER ANNOUNCES STRATEGIC PARTNERSHIPS WITH HOTELBEDS & WEBBEDSHopper customers and its B2B partners gain access to 700,000+ hotel properties worldwideTORONTO, Sept. 28, 2023 (GLOBE NEWSWIRE) — Stack Capital Group Inc., (TSX:STCK and STCK.WT) is pleased to announce that Hopper, Inc. (“Hopper”), an existing portfolio holding, has entered into strategic partnerships with Hotelbeds, a global leader in the TravelTech space, and WebBeds, a global marketplace which provides powerful distribution solutions that make the buying and selling of travel products easier. As the third largest online travel agency in the United States, with 100+ million app downloads, these new partnerships allow Hopper to ‘super-charge’...

Continue reading

Intention to Make a Normal Course Issuer Bid for Subordinate Voting Shares and Preferred Shares

TORONTO, Sept. 28, 2023 (GLOBE NEWSWIRE) — Fairfax Financial Holdings Limited (“Fairfax”) (TSX: FFH and FFH.U) announces that the Toronto Stock Exchange (the “TSX”) has accepted a notice filed by Fairfax of its intention to commence a Normal Course Issuer Bid (“NCIB”) through the facilities of the TSX (or other alternative Canadian trading systems) for its Subordinate Voting Shares and the following series of its Preferred Shares: Cumulative 5-Year Rate Reset Preferred Shares, Series C (“Series C Shares”), Cumulative Floating Rate Preferred Shares, Series D (“Series D Shares”), Cumulative 5-Year Rate Reset Preferred Shares, Series E (“Series E Shares”), Cumulative Floating Rate Preferred Shares, Series F (“Series F Shares”), Cumulative 5-Year Rate Reset Preferred Shares, Series G (“Series G Shares”), Cumulative Floating Rate Preferred...

Continue reading

Draganfly Announces Participation in the LD Micro Main Event XVI and Company Receives Minimum Bid Notification

Los Angeles, CA., Sept. 28, 2023 (GLOBE NEWSWIRE) — Draganfly Inc. (NASDAQ: DPRO) (CSE: DPRO) (FSE: 3U8) (“Draganfly” or the “Company”), an award-winning, industry-leading drone solutions and systems developer, announced today that it will be presenting at the 16th annual LD Micro Main Event at the Luxe Sunset Boulevard Hotel, Los Angeles, California from October 3 to 5, 2023. More than 200 attendees are expected to attend the 16th annual LD Micro Main Event, comprising industry professionals, investors, and entrepreneurs seeking opportunities for growth and collaboration. This platform enables participating companies to present their innovative offerings and connect with like-minded individuals to explore potential avenues for expansion. Draganfly President and CEO Cameron Chell will present on October 3rd, 1 pm PST. We invite...

Continue reading

Renalytix Reports Full Year Fiscal 2023 Results

LONDON and SALT LAKE CITY, Sept. 28, 2023 (GLOBE NEWSWIRE) — Renalytix plc (NASDAQ: RNLX) (LSE: RENX), an artificial intelligence-enabled in vitro diagnostics company, focused on optimizing clinical management of kidney disease to drive improved patient outcomes and advance value-based care, reports its financial results for the fiscal year ended June 30, 2023. Recent Highlights (including post period events) Regulatory & ReimbursementAchieved FDA De Novo marketing authorization for KidneyIntelX.dkd to assess risk of progressive kidney function decline in adults with diabetes and early-stage kidney disease. Secured additional key insurance coverage contracts for KidneyIntelX including:EmblemHealth, covering over three million lives in New York Tri-state region CareFirst BlueCross BlueShield, the largest health care plan...

Continue reading

Karolinska Development’s portfolio company PharmNovo reports promising preclinical results on abuse potential and withdrawal symptom relief for its candidate drug PN6047

STOCKHOLM, SWEDEN, September 28, 2023. Karolinska Development AB (Nasdaq Stockholm: KDEV) announces that its portfolio company PharmNovo has reported promising results in a preclinical study of the company’s drug candidate PN6047. The results reaffirm existing safety profile data of PN6047, which is planned to enter clinical phase 2 trials in 2024. PharmNovo is developing a novel treatment for nerve pain, a difficult-to-treat form of pain that often develops into a chronic condition. The company’s drug candidate PN6047 is a novel candidate drug that was spun off from cutting-edge research at AstraZeneca and is currently being evaluated in a clinical phase 1 study. These new preclinical results show that the drug candidate does not induce drug abuse behavior in non-clinical test models and indicates the capacity to reduce opioid withdrawal...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.